Clinical trials in La Palma, CA

13 recruiting studies have a site in or near La Palma, CA, California.

Top conditions here

All conditions

Showing 13 of 13 studies

RecruitingPhase 3NCT07190209

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Sponsor: Sanofi

La Palma, CA · Long Beach, CA · Los Angeles, CA · +72 more sites

RecruitingPhase 3NCT06617325

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Sponsor: UCB Biopharma SRL

Beverly Hills, CA · La Jolla, CA · +60 more sites

RecruitingPhase 2NCT07409181

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Sponsor: Boehringer Ingelheim

Beverly Hills, CA · La Palma, CA · San Diego, CA · +27 more sites

RecruitingPhase 3NCT06133972

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Sponsor: Novartis Pharmaceuticals

Burbank, CA · La Palma, CA · Westlake Village, CA · +22 more sites

RecruitingPhase not listedNCT07556159

A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

Sponsor: Sanofi

California City, CA · La Palma, CA · Los Angeles, CA · +60 more sites

RecruitingPhase 3NCT06283966

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Sponsor: AstraZeneca

Apple Valley, CA · Canoga Park, CA · Castroville, CA · +232 more sites

RecruitingPhase 3NCT07430306

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Sponsor: AstraZeneca

Fontana, CA · La Jolla, CA · La Palma, CA · +28 more sites

RecruitingPhase 3NCT07438496

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Sponsor: Janssen Research & Development, LLC

Beverly Hills, CA · Fullerton, CA · Hemet, CA · +35 more sites

RecruitingPhase 3NCT05125302

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Sponsor: AbbVie

Anaheim, CA · Fresno, CA · La Palma, CA · +122 more sites

RecruitingPhase not listedNCT07175285

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Sponsor: Bristol-Myers Squibb

La Jolla, CA · La Palma, CA · Los Angeles, CA · +23 more sites

RecruitingPhase 2 / Phase 3NCT07363694

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Sponsor: Pfizer

La Palma, CA · Newport Beach, CA · Northridge, CA · +58 more sites

RecruitingPhase not listedNCT07379827

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

Sponsor: Bristol-Myers Squibb

Anaheim, CA · Chino, CA · +52 more sites

RecruitingPhase 1 / Phase 2NCT06625671

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

Sponsor: DualityBio Inc.

La Palma, CA · +5 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.